Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
2.590
+0.080 (3.19%)
At close: Apr 2, 2025, 4:00 PM
2.569
-0.021 (-0.81%)
After-hours: Apr 2, 2025, 6:00 PM EDT

Evoke Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
13.64.749.849.148.07
Upgrade
Cash & Short-Term Investments
13.64.749.849.148.07
Upgrade
Cash Growth
186.88%-51.85%7.64%13.33%42.46%
Upgrade
Receivables
2.420.670.620.30.02
Upgrade
Inventory
0.450.480.290.190.24
Upgrade
Prepaid Expenses
0.730.890.950.920.92
Upgrade
Other Current Assets
0.040.050.010.010.03
Upgrade
Total Current Assets
17.246.8311.7210.569.28
Upgrade
Property, Plant & Equipment
0.15-0.130.010.14
Upgrade
Long-Term Deferred Charges
0.120.24---
Upgrade
Other Long-Term Assets
0.01---0.01
Upgrade
Total Assets
17.527.0711.8510.579.43
Upgrade
Accounts Payable
2.041.610.870.871.27
Upgrade
Accrued Expenses
3.182.940.590.521.02
Upgrade
Short-Term Debt
----0.1
Upgrade
Current Portion of Long-Term Debt
55---
Upgrade
Current Portion of Leases
0.06-0.130.010.14
Upgrade
Other Current Liabilities
0.10.10.07-5
Upgrade
Total Current Liabilities
10.389.651.651.417.54
Upgrade
Long-Term Debt
--555
Upgrade
Long-Term Leases
0.1----
Upgrade
Other Long-Term Liabilities
--1.110.610.11
Upgrade
Total Liabilities
10.489.657.777.0212.65
Upgrade
Common Stock
00000
Upgrade
Additional Paid-In Capital
135.83120.86119.73110.9895.67
Upgrade
Retained Earnings
-128.79-123.44-115.65-107.42-98.89
Upgrade
Shareholders' Equity
7.04-2.584.083.56-3.21
Upgrade
Total Liabilities & Equity
17.527.0711.8510.579.43
Upgrade
Total Debt
5.1655.135.015.25
Upgrade
Net Cash (Debt)
8.44-0.264.714.132.82
Upgrade
Net Cash Growth
--14.09%46.38%-48.91%
Upgrade
Net Cash Per Share
4.43-0.9418.0018.4915.95
Upgrade
Filing Date Shares Outstanding
2.020.710.280.230.22
Upgrade
Total Common Shares Outstanding
2.010.280.280.230.18
Upgrade
Working Capital
6.86-2.8210.079.151.75
Upgrade
Book Value Per Share
3.49-9.2614.6615.68-17.39
Upgrade
Tangible Book Value
7.04-2.584.083.56-3.21
Upgrade
Tangible Book Value Per Share
3.49-9.2614.6615.68-17.39
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q